Bluejay Diagnostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bluejay Diagnostics, Inc. (Nasdaq: BJDX) on July 21, 2023. The filing reports on a material corporate action approved by stockholders at the Annual Meeting held on June 14, 2023, and formally implemented via a Certificate of Amendment filed with the State of Delaware on July 21, 2023.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a capital structure modification.
Material Changes
The primary material change is the implementation of a 1-for-20 reverse stock split of the Company's common stock. Key details include:
- Effective Date: The split is effective as of 12:01 a.m. Eastern Time on July 24, 2023.
- Share Count Reduction: Issued and outstanding shares will be reduced from approximately 20,466,890 to approximately 1,023,344.
- Authorized Shares: The number of authorized shares under the Charter is reduced from 100,000,000 to 7,500,000.
- Trading Symbol: The symbol remains "BJDX" on The Nasdaq Capital Market.
- Fractional Shares: No fractional shares will be issued. Stockholders entitled to fractional shares will receive a cash payment based on the average closing price of the ten consecutive trading days ending two days prior to the effective date.
- Equity Awards: Exercise prices and share counts for outstanding equity awards and warrants will be proportionately adjusted.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the standard mechanics of the reverse stock split. The Company notes that the split does not alter the par value of the common stock or modify voting rights.
Investor Verification Checklist
- Verify the new CUSIP number for post-split shares: 095633301.
- Confirm the effective trading date of July 24, 2023, for post-split shares on Nasdaq.
- Review instructions from brokers or the transfer agent (Continental Stock Transfer & Trust Company) regarding the exchange of pre-split certificates and the receipt of cash for fractional shares.
- Check the adjustment of exercise prices and share quantities for any held options or warrants.